Why Brazil

  • Pharma Market

    Brazil is the biggest country in Latin America in terms of area, population and pharmaceutical market.

  • Population

    Population is approximately 213 million, with a growth rate of 0.7% (2026).

  • Capital & Major City

    Brasília is the capital, while São Paulo is the most populous city, with approximately 46 million people in its metropolitan region (2026).

  • Pharma Market Size

    The total pharmaceutical market is approximately USD 40 billion.

  • Rapid Market Growth

    Driven by an aging population and strong demand for generics, the Brazilian market is projected to grow at a CAGR of 8.77% through 2032, reaching approximately USD 73.79 billion.

  • Global Pharmaceutical Ranking

    Brazil ranks among the world's largest pharmaceutical markets by revenue, according to industry sources including Sinduspharma and Statista.

  • Aging Population

    Accelerated growth is supported by an aging population, with people over 60 expected to represent around 25% of the population by 2034, alongside rising demand for chronic disease treatments.

  • Retail vs. Public Market

    Retail pharmacies account for approximately 66% of revenue and 89% of units sold, while public procurement through hospitals and clinics represents the remaining 34% of revenue.

  • Generics & Similar Drugs

    Generics and similar drugs account for roughly 70% of total units sold, highlighting strong demand for affordable medicines.

  • Highly Regulated Market

    The pharmaceutical sector is heavily regulated, with strict regulations and government-approved pricing for new and existing medicines through CMED.